Forever Chemicals, Federal Oversight, and the Changing Regulatory Landscape
On March 11, 2026, the U.S. Food and Drug Administration (FDA) announced the launch of the Adverse Event Monitoring System (AEMS), a centralized, AI-driven platform
FDA’s Valentine’s Day Reminder for OTC Drug Claims
What the Human Foods Agenda Means for Regulated Businesses
(Yes, it’s that time of year again — compliance season!)
